GA Telesis Walks Around the Globe in Support of St. Jude Children’s Hospital
October 15, 2014 – Fort Lauderdale, FL. – GA Telesis, LLC is contributing to this year’s “St. Jude Give thanks. Walk” initiative to help raise money for children with life-threatening conditions and illnesses. The company will be hosting a Walk-A-Thon at their offices around the globe on Friday, October 17th, in order to raise funds for the hospital. With offices in the United States, United Kingdom, China, Finland, Turkey and Australia, GA Telesis employees will be walking “around the globe” for 24 hours straight. Representatives from the company will also participate in St. Jude’s family-friendly 5k walk to be held at Jungle Island in Miami, Florida on November 22nd.
About GA Telesis
GA Telesis is a worldwide leader in providing support services to the commercial aerospace industry. With financial, supply-chain, component and heavy jet engine MRO businesses spanning the globe, GA Telesis is recognized as a pioneering leader in solutions-based services in its sector. As an innovator, GA Telesis is one of the few independent companies in the world capable of providing a total-support-solution to their customers from their front door with several fully integrated operations throughout North America, Europe and Asia. GA Telesis also provides leasing and asset management services and maintains an extensive portfolio of leased assets exceeding $1 billion in value.
About St. Jude Children’s Hospital
St. Jude Children’s Research Hospital is leading the way in which the world understands, treats, and defeats childhood cancer and other life-threatening diseases. Their services — including treatment, housing, travel, and food — are provided to patients free of charge. Additionally, St. Jude has the world’s best survival rates for some of the most aggressive childhood cancers, and treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since it opened more than 50 years ago. St. Jude is working to drive the overall survival rate for childhood cancer to 90% in the next decade.